More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
AUM
$3.03B
P/E ratio
26.2
Dividend yield
--
Expense ratio
0.55%
Beta
0.675029
Previous close
$266.97
Today's open
$265.78
Day's range
$264.03 - $267.39
52 week range
$189.47 - $283.21
Industries
Health
GMAB
Genmab AS ADR
4.89%
3.95%
3.77%
EXEL
Exelixis Inc
3.68%
3.59%
BIIB
Biogen Inc
3.57%
AMGN
Amgen Inc
3.57%
ALKS:IE
Alkermes PLC
3.55%
3.51%
VCYT
Veracyte Inc
3.51%
Two Ways to Play Biotech: FBT's Return Edge vs. IBB's Cost Advantage
First Trust NYSE Arca Biotechnology Index Fund maintains a more concentrated portfolio of 30 holdings compared to the 243 positions found in iShares Biotechnology ETF. iShares Biotechnology ETF carries a lower expense ratio of 0.44% whereas First Trust NYSE Arca Biotechnology Index Fund charges 0.55%.
The Motley Fool • Nov 14, 2026

Better Biotech ETF: First Trust's FBT vs. Invesco's PBE
The First Trust NYSE Arca Biotechnology Index Fund has a lower expense ratio and significantly higher assets under management (AUM). The First Trust NYSE Arca Biotechnology Index Fund outperformed the Invesco fund on a 1-year total return basis and over a five-year period.
The Motley Fool • Nov 14, 2026

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Making its debut on 06/19/2006, smart beta exchange traded fund First Trust NYSE Arca Biotechnology ETF (FBT) provides investors broad exposure to the Health Care ETFs category of the market.
Zacks Investment Research • Nov 11, 2026

Drug Makers or Biotech Bets: Which ETF Is the Better Buy, State Street's XPH or First Trust's FBT?
State Street SPDR S&P Pharmaceuticals ETF offers a lower expense ratio of 0.35% compared to 0.55% for the First Trust fund. First Trust NYSE Arca Biotechnology Index Fund has delivered higher total returns over the past one-year and five-year periods.
The Motley Fool • Nov 11, 2026

Which Is the Better Buy: iShares' Pharma ETF IHE or First Trust's Biotech Fund FBT?
iShares U.S. Pharmaceuticals ETF has a lower expense ratio than the First Trust NYSE Arca Biotechnology Index Fund. First Trust NYSE Arca Biotechnology Index Fund maintains a more concentrated portfolio.
The Motley Fool • Nov 11, 2026

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund launched on June 19, 2006.
Zacks Investment Research • Nov 4, 2026

ETFs That You May Consider Amid a Strengthening Biotech Outlook
Drug innovation, AI and rising M&A activity are boosting biotech optimism. Discover ETFs offering exposure to the sector.
Zacks Investment Research • Oct 28, 2026

Which Healthcare ETF Is the Better Buy: Simplify's Mission-Driven PINK or First Trust's Biotech FBT?
First Trust NYSE Arca Biotechnology Index Fund tracks a concentrated index of 30 biotech stocks, while Simplify Health Care ETF is an actively managed fund with broader healthcare exposure. Simplify Health Care ETF features a lower expense ratio and has experienced a significantly lower maximum drawdown over the last five years compared to the First Trust fund.
The Motley Fool • Oct 27, 2026

Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT?
iShares Global Healthcare ETF offers a lower expense ratio and broader sector exposure than First Trust NYSE Arca Biotechnology Index Fund. First Trust NYSE Arca Biotechnology Index Fund focuses exclusively on biotechnology while iShares Global Healthcare ETF includes pharmaceuticals and equipment.
The Motley Fool • Oct 26, 2026

Which Healthcare ETF Is the Better Buy: Invesco's Broad RSPH or First Trust's Biotech FBT?
First Trust NYSE Arca Biotechnology Index Fund has delivered significantly higher 1-year total returns but with greater volatility and a deeper maximum drawdown. Invesco S&P 500 Equal Weight Health Care ETF provides broader sector coverage, whereas the First Trust fund is a concentrated play on 30 biotechnology firms.
The Motley Fool • Oct 26, 2026

¹ Disclosures

Open an M1 investment account to buy and sell First Trust NYSE Arca Biotechnology Index Fund commission-free¹. Build wealth for the long term using automated trading and transfers.